Benzothiazole based inhibitors of p38α MAP kinase
- 15 March 2008
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (6), 1874-1879
- https://doi.org/10.1016/j.bmcl.2008.02.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Design, Synthesis, and Anti-inflammatory Properties of Orally Active 4-(Phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α Mitogen-Activated Protein Kinase InhibitorsJournal of Medicinal Chemistry, 2007
- Discovery and Optimization of p38 Inhibitors via Computer-Assisted Drug DesignJournal of Medicinal Chemistry, 2007
- p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffoldBioorganic & Medicinal Chemistry Letters, 2006
- 5-Cyanopyrimidine Derivatives as a Novel Class of Potent, Selective, and Orally Active Inhibitors of p38α MAP KinaseJournal of Medicinal Chemistry, 2005
- The Biology of p38 Kinase: A Central Role in InflammationCurrent Topics in Medicinal Chemistry, 2005
- The p38 MAP kinase pathway as a therapeutic target in inflammatory diseaseCurrent Opinion in Pharmacology, 2004
- Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritisBioorganic & Medicinal Chemistry Letters, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- 1 p38 MAP Kinase: Molecular Target for the Inhibition of Pro-inflammatory CytokinesProgress in Medicinal Chemistry, 2001
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994